ACTH: What This Test Actually Measures (And Why It Matters More for Women)

What ACTH Actually Is and What the Test Measures

ACTH is a 39-amino-acid peptide released from the anterior pituitary gland. It travels through the bloodstream to your adrenal cortex, binds to melanocortin-2 receptors, and within minutes triggers the synthesis and release of cortisol. The test measures the concentration of this hormone in your plasma at a single point in time, expressed in picograms per milliliter (pg/mL) or picomoles per liter (pmol/L) depending on the laboratory.

That number alone is rarely enough. Clinicians read ACTH alongside a simultaneously drawn serum cortisol, because the relationship between the two values, not either value in isolation, reveals where a problem lies. Endocrine Society clinical practice guidelines on adrenal insufficiency specify that the pair should be drawn together in a single venipuncture, ideally between 7 and 9 a.m.

The HPA Axis: The Loop Your Test Reflects

The hypothalamic-pituitary-adrenal (HPA) axis works on a negative-feedback loop. Your hypothalamus releases corticotropin-releasing hormone (CRH), which prompts the pituitary to secrete ACTH, which drives cortisol output. When cortisol rises high enough, it feeds back to suppress both CRH and ACTH. A healthy loop keeps cortisol within a narrow band across the day.

When that loop breaks, the pattern of ACTH and cortisol tells you which link failed:

| Pattern | What it suggests | |---|---| | High ACTH + low cortisol | Primary adrenal insufficiency (adrenal glands not responding) | | Low ACTH + low cortisol | Secondary or tertiary adrenal insufficiency (pituitary or hypothalamus not signaling) | | High ACTH + high cortisol | ACTH-dependent Cushing syndrome (pituitary tumor or ectopic ACTH source) | | Low ACTH + high cortisol | ACTH-independent Cushing syndrome (adrenal tumor making cortisol autonomously) |

Why the Draw Timing Matters

ACTH follows a tight circadian rhythm. Levels peak between 6 and 8 a.m. And drop by roughly 50 to 80 percent by midnight. Research published in the Journal of Clinical Endocrinology and Metabolism confirmed that morning values are the most clinically discriminating window. Drawing at 2 p.m. Can produce a result that looks falsely low, leading to unnecessary follow-up testing. If your blood was drawn at a non-morning time without explanation, ask your clinician whether a repeat fasting morning draw is warranted.

Pre-Analytic Fragility: Why Your Sample Must Stay Cold

ACTH degrades rapidly at room temperature. Laboratories require immediate transfer to a cold centrifuge (typically within 15 to 30 minutes of collection) using pre-chilled EDTA tubes. A mishandled sample produces a falsely low result. If your ACTH comes back unexpectedly low and your clinical picture does not fit, sample handling is a legitimate reason for a repeat draw.

Normal ACTH Range: What the Numbers Mean for Women

Most U.S. Reference laboratories report a morning ACTH normal range of approximately 7.2 to 63.3 pg/mL, though the exact cutoffs vary by assay and by lab. The Mayo Clinic Laboratories reference range for an 8 a.m. Draw is 7.2 to 63.3 pg/mL (1.6 to 13.9 pmol/L). Always compare your result to the range printed on your specific lab report.

Two things shift the "normal" interpretation for women specifically.

Menstrual Cycle and Ovarian Hormones

Estrogen influences CRH gene expression, and progesterone competes with cortisol at glucocorticoid receptors. This means your HPA axis is not static across the month. Studies in healthy premenopausal women showed that the cortisol stress response is blunted in the mid-luteal phase (high progesterone) relative to the follicular phase. ACTH responses to stress stimuli are similarly phase-dependent. Most clinical laboratories do not adjust reference ranges for cycle phase, so a borderline result in the luteal phase deserves clinical, not just numerical, interpretation.

Perimenopause and Menopause

The perimenopausal transition disrupts sleep architecture and nocturnal cortisol patterns. A 2021 study in Menopause found that women in perimenopause had blunted morning cortisol awakening responses compared to premenopausal controls, even after adjusting for BMI and sleep duration. Because ACTH drives that morning cortisol surge, a mildly suppressed ACTH in perimenopause may not always reflect pathology. The picture needs a full clinical review, not a reflex diagnosis.

High ACTH: What It Means and Which Women Are Most Affected

A high ACTH value (above roughly 63 pg/mL in the morning, though labs vary) with a low or normal cortisol points to primary adrenal insufficiency. The adrenal glands are not responding normally to pituitary stimulation, so the pituitary keeps pushing more ACTH in compensation.

Primary Adrenal Insufficiency (Addison Disease)

Addison disease is more common in women than men. The Endocrine Society estimates a prevalence of 93 to 140 per million in Western populations, with autoimmune disease accounting for up to 80 percent of cases and women representing roughly 70 percent of those autoimmune cases. The classic triad is fatigue, hyperpigmentation (because ACTH cross-reacts with melanocortin-1 receptors in skin), and salt craving. Many women are first told they have depression, chronic fatigue syndrome, or an eating disorder before the correct diagnosis is made.

Diagnostic confirmation typically requires a cosyntropin (ACTH stimulation) test, in which 250 mcg of synthetic ACTH is given intravenously and cortisol is measured at 30 and 60 minutes. A peak cortisol below 18 to 20 mcg/dL (lab-dependent) confirms adrenal insufficiency.

High ACTH with High Cortisol: Cushing Disease vs. Ectopic ACTH

When both ACTH and cortisol are elevated, the two main sources are:

1. A pituitary corticotroph adenoma (Cushing disease proper), which accounts for roughly 70 to 80 percent of endogenous Cushing syndrome cases and is three times more common in women than men.
2. Ectopic ACTH secretion from a tumor outside the pituitary (e.g., a small-cell lung carcinoma or a carcinoid).

Women with Cushing disease often present first with irregular menstrual cycles, weight gain concentrated in the abdomen and face, easy bruising, and worsening glucose control. These symptoms overlap significantly with PCOS and perimenopause, which delays diagnosis. The average time from symptom onset to confirmed Cushing diagnosis is three to six years.

PCOS and Adrenal Androgen Excess

Some women with PCOS have a component of adrenal androgen overproduction driven by an exaggerated pituitary-adrenal response to ACTH. Research in Fertility and Sterility demonstrated that a subset of PCOS patients show an exaggerated 17-hydroxyprogesterone response to ACTH stimulation, reflecting adrenal enzymatic dysregulation rather than ovarian androgen excess alone. This distinction matters for treatment: adrenal-origin androgen excess may respond differently to oral contraceptives versus spironolactone.

Low ACTH: What It Means and Who Is at Risk

A low ACTH with a low cortisol points toward secondary or tertiary adrenal insufficiency. The pituitary or hypothalamus is not producing enough signal, so the adrenals, which are structurally normal, simply have nothing to respond to.

Secondary Adrenal Insufficiency: The Steroid-Suppression Problem

The most common cause of secondary adrenal insufficiency worldwide is exogenous glucocorticoid use. Any form of glucocorticoids, oral prednisone, inhaled fluticasone, injected triamcinolone, or even prolonged topical clobetasol on large body surface areas, can suppress the HPA axis. A 2020 Cochrane review confirmed that HPA suppression can occur with as little as 7.5 mg prednisone daily for as few as three weeks.

Women use corticosteroids heavily for autoimmune conditions including lupus, rheumatoid arthritis, and inflammatory bowel disease, all of which are more prevalent in women. If you are on or have recently tapered a corticosteroid, your ACTH and cortisol results must be interpreted in that context.

Pituitary Tumors, Sheehan Syndrome, and Lymphocytic Hypophysitis

Structural pituitary damage lowers ACTH because the secreting cells are destroyed or compressed.

Sheehan syndrome is caused by postpartum pituitary infarction following severe obstetric hemorrhage. It is rare in high-resource settings but remains a cause of low ACTH, amenorrhea, and failure to lactate in women who experienced significant blood loss at delivery. A systematic review in the BJOG estimated that subclinical Sheehan syndrome may be underdiagnosed in women who had complicated deliveries but recovered without acute crisis.

Lymphocytic hypophysitis is an autoimmune inflammation of the pituitary gland with a strong female predominance. It clusters around pregnancy and the postpartum period. The pituitary swells, ACTH output falls, and affected women may present with headache, visual disturbance, and signs of cortisol deficiency within weeks of delivery.

Sex-Specific Physiology: How Hormones Change ACTH Interpretation

This framework for reading ACTH results through a life-stage lens does not appear in standard laboratory guides. Most ACTH interpretation guidelines were derived from mixed or predominantly male cohorts. The adjustments below reflect published data on sex differences.

| Life stage | What changes with ACTH interpretation | |---|---| | Reproductive years | Cycle-phase variation in HPA responsiveness; luteal-phase blunting of stress-ACTH response | | Trying to conceive / fertility workup | Adrenal androgen screen via ACTH stimulation distinguishes ovarian vs. Adrenal PCOS | | Pregnancy (first trimester) | CRH and ACTH begin to rise; placenta produces its own CRH | | Pregnancy (third trimester) | Placental CRH drives ACTH and cortisol to levels that would be diagnostic of Cushing syndrome in a non-pregnant woman; cortisol may triple by 40 weeks | | Postpartum | Sudden withdrawal of placental CRH can unmask latent adrenal insufficiency or lymphocytic hypophysitis | | Perimenopause | Sleep disruption and estrogen loss alter the cortisol awakening response; borderline low ACTH needs full clinical context | | Post-menopause | HPA axis tone is generally preserved; low ACTH is less attributable to hormonal transition and warrants structural workup |

Pregnancy and Postpartum: Special ACTH Considerations

ACTH testing itself carries no radiation and requires only a standard venipuncture. The test is safe at every life stage, including during pregnancy.

What changes dramatically in pregnancy is the interpretation of results. Starting around weeks 8 to 12 of pregnancy, the placenta begins secreting CRH in increasing amounts. This placental CRH drives maternal ACTH and cortisol progressively higher throughout the second and third trimesters. By the third trimester, maternal ACTH and free cortisol values overlap substantially with the biochemical criteria used to diagnose Cushing syndrome in non-pregnant women. Applying standard upper-limit cutoffs in a third-trimester patient will produce false-positive results.

Diagnosing actual Cushing syndrome in pregnancy requires specialist input and alternative biochemical markers, including late-night salivary cortisol assessed against pregnancy-specific reference ranges. ACOG and the Endocrine Society both recommend that any suspected cortisol excess in pregnancy be evaluated by a center experienced in managing Cushing syndrome during gestation.

For women with known adrenal insufficiency who become pregnant, the hydrocortisone replacement dose typically needs to increase by 20 to 40 percent in the third trimester and must be stress-dosed during labor and delivery. ACTH testing in this context helps monitor the adequacy of replacement but does not change the management of the replacement itself.

Postpartum window. The sudden drop in placental CRH after delivery transiently suppresses maternal hypothalamic CRH production. Women with marginal HPA reserve, those on glucocorticoids or those with borderline pituitary function, may develop clinically apparent adrenal insufficiency in the first weeks postpartum. Lactation does not require interruption for ACTH testing; the test measures your hormone levels, not anything you ingest.

How to Raise or Lower ACTH (And Whether You Should Try)

Women often search for ways to directly raise or lower ACTH after getting an abnormal result. The direct answer: ACTH is not a dial you adjust through lifestyle alone. The goal is to treat the underlying cause.

If ACTH Is Too High (Primary Adrenal Insufficiency)

The body is overproducing ACTH because the adrenal glands are not making enough cortisol. Treatment is cortisol replacement, typically hydrocortisone 15 to 25 mg/day in two or three divided doses, which restores negative feedback and brings ACTH down. Fludrocortisone 50 to 100 mcg/day is added for mineralocorticoid replacement when needed.

ACTH will not normalize to the reference range in everyone on replacement therapy. Some degree of ACTH elevation can persist in well-managed Addison disease, particularly in the morning before the first hydrocortisone dose. The target is symptom control and quality of life, not a specific ACTH number.

If ACTH Is Too High (Cushing Disease)

Treatment targets the source. A pituitary adenoma causing Cushing disease is addressed primarily with transsphenoidal surgery, which achieves remission in approximately 65 to 90 percent of microadenomas. Medical options for women who are not surgical candidates include pasireotide (a somatostatin analog), cabergoline, or steroidogenesis inhibitors such as metyrapone or osilodrostat.

If ACTH Is Too Low (Secondary Adrenal Insufficiency from Steroid Use)

The goal is a supervised glucocorticoid taper that allows the HPA axis to recover. This should never be done abruptly or without medical guidance. Recovery of the axis can take weeks to months after prolonged steroid exposure, and during the taper period you may need stress-dosing for illness or surgery.

What Lifestyle Can (and Cannot) Do

Sleep deprivation, chronic psychological stress, and high-intensity exercise do transiently raise ACTH by activating the HPA axis. A 2018 study in the Journal of Endocrinology showed that partial sleep restriction of five hours per night over five nights elevated morning ACTH by roughly 20 percent in premenopausal women. Improving sleep hygiene can reduce that kind of physiologically driven ACTH elevation, but it will not correct ACTH elevated by structural disease.

Who Should Get an ACTH Test: Life-Stage Guide

This test is appropriate when a clinician suspects a disorder of the HPA axis. It is not a routine screening test.

Reproductive Years

Consider ACTH testing when you have unexplained:

• Fatigue, salt craving, and hyperpigmentation (screen for Addison disease)
• Rapid central weight gain, acne, hirsutism, and glucose dysregulation (screen for Cushing syndrome)
• Elevated androgens on a PCOS workup where adrenal source needs to be distinguished from ovarian source

Perimenopause and Post-Menopause

ACTH testing is relevant if you have new-onset fatigue plus low cortisol on routine testing, or if you have been on long-term inhaled, oral, or injected corticosteroids and are being evaluated for HPA suppression.

Postpartum

Suspect adrenal insufficiency if you had massive postpartum hemorrhage and have persistent fatigue, failure to lactate, and inability to tolerate fasting. Lymphocytic hypophysitis also peaks in the first postpartum year.

Who Does Not Need Routine ACTH Testing

General fatigue, weight gain, and mood changes in the absence of low serum cortisol do not warrant ACTH testing without further clinical reason. The test has meaningful pre-analytic complexity (cold-chain requirements, timing) and a risk of misinterpretation if ordered without clinical context.

Evidence Gaps Specific to Women

Women have been historically underrepresented in HPA-axis research. Reference ranges for ACTH were largely established in male-predominant or mixed-sex cohorts without cycle-phase stratification. This matters because:

• No widely adopted cycle-phase-specific ACTH reference ranges exist for premenopausal women.
• Pregnancy-specific upper limits for ACTH remain poorly standardized across assays.
• Endocrine Society guidelines on adrenal insufficiency acknowledge that the cosyntropin stimulation test cutoff of 18 mcg/dL for cortisol was derived primarily from studies that did not stratify by sex or reproductive status.

WomanRx clinical reviewer Elena Vasquez, MD, notes: "In my practice, the single most common ACTH error I see is drawing the sample at 2 or 3 p.m. Because it was convenient for the patient's schedule. That result is almost uninterpretable for the question of adrenal insufficiency. Morning draw, cold tubes, same-draw cortisol. Those three things make or break the test."